Free Newsletter
U.K. scrutinizes antipsychotic use
Add to a host of U.S. probes a new U.K. look at the use of antipsychotic drugs in dementia patients. British ministers have ordered a review of the meds, which have been linked to an increased risk of death in elderly patients with dementia, but continue to be used to pacify aggressive and disturbed patients. It's part of a new effort in the U.K. to codify dementia treatment, in anticipation of a huge increase in cases as the population ages.
- read the BBC report
- check out the story in The Guardian
Related Articles:
Enbrel, antipsychotics draw warning fire
Did Lilly chief support off-label antipsychotic promos?
U.K. kids' antipsychotic use doubled
More stories about antipsychotics
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession






SHARE
WITH: